288 related articles for article (PubMed ID: 11981795)
1. Alteplase and tenecteplase: applications in the peripheral circulation.
Semba CP; Sugimoto K; Razavi MK;
Tech Vasc Interv Radiol; 2001 Jun; 4(2):99-106. PubMed ID: 11981795
[TBL] [Abstract][Full Text] [Related]
2. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
[TBL] [Abstract][Full Text] [Related]
3. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction.
Dunn CJ; Goa KL
Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052
[TBL] [Abstract][Full Text] [Related]
4. Tenecteplase for Acute Ischemic Stroke Treatment.
Baird AE; Jackson R; Jin W
Semin Neurol; 2021 Feb; 41(1):28-38. PubMed ID: 33472268
[TBL] [Abstract][Full Text] [Related]
5. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA).
Gibson CM; Marble SJ
Clin Cardiol; 2001 Sep; 24(9):577-84. PubMed ID: 11558838
[TBL] [Abstract][Full Text] [Related]
6. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
[TBL] [Abstract][Full Text] [Related]
7. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion.
Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV;
Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of tenecteplase in acute myocardial infarction.
Guerra DR; Karha J; Gibson CM
Expert Opin Pharmacother; 2003 May; 4(5):791-8. PubMed ID: 12740001
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits.
Lapchak PA; Araujo DM; Zivin JA
Exp Neurol; 2004 Jan; 185(1):154-9. PubMed ID: 14697326
[TBL] [Abstract][Full Text] [Related]
10. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
Hailu K; Cannon C; Hayes S
Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
[TBL] [Abstract][Full Text] [Related]
11. Tenecteplase: a review.
Davydov L; Cheng JW
Clin Ther; 2001 Jul; 23(7):982-97; discussion 981. PubMed ID: 11519775
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.
Tanswell P; Modi N; Combs D; Danays T
Clin Pharmacokinet; 2002; 41(15):1229-45. PubMed ID: 12452736
[TBL] [Abstract][Full Text] [Related]
13. Comparative fibrinolytic activity of front-loaded alteplase and the single-bolus mutants tenecteplase and lanoteplase during treatment of acute myocardial infarction.
Al-Shwafi KA; de Meester A; Pirenne B; Col JJ
Am Heart J; 2003 Feb; 145(2):217-25. PubMed ID: 12595837
[TBL] [Abstract][Full Text] [Related]
14. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
Serebruany VL; Malinin AI; Callahan KP; Binbrek A; Van De Werf F; Alexander JH; Granger CB; Gurbel PA;
Am Heart J; 2003 Apr; 145(4):636-42. PubMed ID: 12679759
[TBL] [Abstract][Full Text] [Related]
15. Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplase.
Gomaraschi M; Ossoli A; Vitali C; Pozzi S; Vitali Serdoz L; Pitzorno C; Sinagra G; Franceschini G; Calabresi L
Biochem Pharmacol; 2013 Feb; 85(4):525-30. PubMed ID: 23219857
[TBL] [Abstract][Full Text] [Related]
16. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
Burgos AM; Saver JL
Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
[TBL] [Abstract][Full Text] [Related]
17. Tenecteplase Thrombolysis for Acute Ischemic Stroke.
Warach SJ; Dula AN; Milling TJ
Stroke; 2020 Nov; 51(11):3440-3451. PubMed ID: 33045929
[TBL] [Abstract][Full Text] [Related]
18. Choosing the Correct "-ase" in Acute Ischemic Stroke: Alteplase, Tenecteplase, and Reteplase.
Dillon GM; Stevens S; Dusenbury WL; Massaro L; Toy F; Purdon B
Adv Emerg Nurs J; 2019; 41(3):271-278. PubMed ID: 31356253
[TBL] [Abstract][Full Text] [Related]
19. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
20. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.
Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM
Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
